APO Research
Talk to an analyst

APO RESEARCH · REPORT

Cell and Gene Therapy Supply Chain and Logistics

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Cell and Gene Therapy Supply Chain and Logistics Market Analysis and Forecast 2026-2032

11 April 2026194 pages

Choose your research edition.

Industry ResearchCell and Gene Therapy Supply Chain and Logistics Industry Research Report 2026126 pages · $2,950 USDIndustry Growth & TrendsGlobal Cell and Gene Therapy Supply Chain and Logistics Industry Growth and Trends Forecast to 2032112 pages · $3,450 USDMarket StructureGlobal Cell and Gene Therapy Supply Chain and Logistics Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032194 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Cell and Gene Therapy Supply Chain and Logistics Market Outlook and Growth Opportunities 2026$4,250 USDMarket Analysis & ForecastGlobal Cell and Gene Therapy Supply Chain and Logistics Market Analysis and Forecast 2026-2032194 pages · $4,950 USD

Market perspective

The global Cell and Gene Therapy Supply Chain and Logistics market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The North America market for Cell and Gene Therapy Supply Chain and Logistics is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Cell and Gene Therapy Supply Chain and Logistics is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Cell and Gene Therapy Supply Chain and Logistics is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Cell and Gene Therapy Supply Chain and Logistics is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global companies of Cell and Gene Therapy Supply Chain and Logistics include Be The Match BioTherapies, Biocair, Marken, World Courier, MAK-SYSTEM, Cryoport, Brooks Life Sciences, Hypertrust Patient Data Care and Haemonetics, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

Report Includes

This report presents an overview of global market for Cell and Gene Therapy Supply Chain and Logistics, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Cell and Gene Therapy Supply Chain and Logistics, also provides the revenue of main regions and countries. Of the upcoming market potential for Cell and Gene Therapy Supply Chain and Logistics, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Cell and Gene Therapy Supply Chain and Logistics revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Cell and Gene Therapy Supply Chain and Logistics market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for Cell and Gene Therapy Supply Chain and Logistics revenue, projected growth trends, production technology, application and end-user industry.

Cell and Gene Therapy Supply Chain and Logistics Segment by Company

Be The Match BioTherapies

Biocair

Marken

World Courier

MAK-SYSTEM

Cryoport

Brooks Life Sciences

Hypertrust Patient Data Care

Haemonetics

MasterControl

TraceLink

TrakCel

Stafa Cellular Therapy

McKesson

BioLife Solutions

Patheon

SF Express

Cell and Gene Therapy Supply Chain and Logistics Segment by Type

Ordering and Scheduling Services

Sample Collection Services

Logistics Services

Post Treatment Follow-Up Services

Cell and Gene Therapy Supply Chain and Logistics Segment by Application

Biobank

Cell Therapy Lab

Hospital

Research Institute

Cell and Gene Therapy Supply Chain and Logistics Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key players, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Cell and Gene Therapy Supply Chain and Logistics market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Cell and Gene Therapy Supply Chain and Logistics and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Cell and Gene Therapy Supply Chain and Logistics.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Revenue of Cell and Gene Therapy Supply Chain and Logistics in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 4: Detailed analysis of Cell and Gene Therapy Supply Chain and Logistics company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Cell and Gene Therapy Supply Chain and Logistics revenue, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, revenue for each segment.

Chapter 9: Europe by type, by application and by country, revenue for each segment.

Chapter 10: China type, by application, revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.

Chapter 13: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Cell and Gene Therapy Supply Chain and Logistics Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Ordering and Scheduling Services Major Player Table 3. Sample Collection Services Major Player Table 4. Logistics Services Major Player Table 5. Post Treatment Follow-Up Services Major Player Table 6. Global Cell and Gene Therapy Supply Chain and Logistics Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 7. Biobank Major Player Table 8. Cell Therapy Lab Major Player Table 9. Hospital Major Player Table 10. Research Institute Major Player Table 11. Cell and Gene Therapy Supply Chain and Logistics Industry Trends Table 12. Cell and Gene Therapy Supply Chain and Logistics Industry Drivers Table 13. Cell and Gene Therapy Supply Chain and Logistics Industry Opportunities and Challenges Table 14. Cell and Gene Therapy Supply Chain and Logistics Industry Restraints Table 15. Global Cell and Gene Therapy Supply Chain and Logistics Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 16. Global Cell and Gene Therapy Supply Chain and Logistics Market Size by Region (2021-2026) & (US$ Million) Table 17. Global Cell and Gene Therapy Supply Chain and Logistics Market Share by Region (2021-2026) Table 18. Global Cell and Gene Therapy Supply Chain and Logistics Market Size by Region (2027-2032) & (US$ Million) Table 19. Global Cell and Gene Therapy Supply Chain and Logistics Market Share by Region (2027-2032) Table 20. Global Cell and Gene Therapy Supply Chain and Logistics Revenue by Players (US$ Million) & (2021-2026) Table 21. Global Cell and Gene Therapy Supply Chain and Logistics Revenue Market Share by Players (2021-2026) Table 22. Global Cell and Gene Therapy Supply Chain and Logistics Key Players Ranking, 2024 VS 2025 VS 2026 Table 23. Global Cell and Gene Therapy Supply Chain and Logistics Key Players Headquarters & Area Served Table 24. Global Cell and Gene Therapy Supply Chain and Logistics Players, Product Type & Application Table 25. Global Cell and Gene Therapy Supply Chain and Logistics Players Establishment Date Table 26. Global Players Market Concentration Ratio (CR5 and HHI) Table 27. Global Cell and Gene Therapy Supply Chain and Logistics by Players Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 28. Global Cell and Gene Therapy Supply Chain and Logistics Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 29. Global Cell and Gene Therapy Supply Chain and Logistics Revenue by Type (2021-2026) & (US$ Million) Table 30. Global Cell and Gene Therapy Supply Chain and Logistics Revenue by Type (2027-2032) & (US$ Million) Table 31. Global Cell and Gene Therapy Supply Chain and Logistics Revenue Market Share by Type (2021-2026) Table 32. Global Cell and Gene Therapy Supply Chain and Logistics Revenue Market Share by Type (2027-2032) Table 33. Global Cell and Gene Therapy Supply Chain and Logistics Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 34. Global Cell and Gene Therapy Supply Chain and Logistics Revenue by Application (2021-2026) & (US$ Million) Table 35. Global Cell and Gene Therapy Supply Chain and Logistics Revenue by Application (2027-2032) & (US$ Million) Table 36. Global Cell and Gene Therapy Supply Chain and Logistics Revenue Market Share by Application (2021-2026) Table 37. Global Cell and Gene Therapy Supply Chain and Logistics Revenue Market Share by Application (2027-2032) Table 38. Be The Match BioTherapies Company Information Table 39. Be The Match BioTherapies Business Overview Table 40. Be The Match BioTherapies Cell and Gene Therapy Supply Chain and Logistics Revenue and Gross Margin (US$ Million) & (2021-2026) Table 41. Be The Match BioTherapies Cell and Gene Therapy Supply Chain and Logistics Product Portfolio Table 42. Be The Match BioTherapies Recent Development Table 43. Biocair Company Information Table 44. Biocair Business Overview Table 45. Biocair Cell and Gene Therapy Supply Chain and Logistics Revenue and Gross Margin (US$ Million) & (2021-2026) Table 46. Biocair Cell and Gene Therapy Supply Chain and Logistics Product Portfolio Table 47. Biocair Recent Development Table 48. Marken Company Information Table 49. Marken Business Overview Table 50. Marken Cell and Gene Therapy Supply Chain and Logistics Revenue and Gross Margin (US$ Million) & (2021-2026) Table 51. Marken Cell and Gene Therapy Supply Chain and Logistics Product Portfolio Table 52. Marken Recent Development Table 53. World Courier Company Information Table 54. World Courier Business Overview Table 55. World Courier Cell and Gene Therapy Supply Chain and Logistics Revenue and Gross Margin (US$ Million) & (2021-2026) Table 56. World Courier Cell and Gene Therapy Supply Chain and Logistics Product Portfolio Table 57. World Courier Recent Development Table 58. MAK-SYSTEM Company Information Table 59. MAK-SYSTEM Business Overview Table 60. MAK-SYSTEM Cell and Gene Therapy Supply Chain and Logistics Revenue and Gross Margin (US$ Million) & (2021-2026) Table 61. MAK-SYSTEM Cell and Gene Therapy Supply Chain and Logistics Product Portfolio Table 62. MAK-SYSTEM Recent Development Table 63. Cryoport Company Information Table 64. Cryoport Business Overview Table 65. Cryoport Cell and Gene Therapy Supply Chain and Logistics Revenue and Gross Margin (US$ Million) & (2021-2026) Table 66. Cryoport Cell and Gene Therapy Supply Chain and Logistics Product Portfolio Table 67. Cryoport Recent Development Table 68. Brooks Life Sciences Company Information Table 69. Brooks Life Sciences Business Overview Table 70. Brooks Life Sciences Cell and Gene Therapy Supply Chain and Logistics Revenue and Gross Margin (US$ Million) & (2021-2026) Table 71. Brooks Life Sciences Cell and Gene Therapy Supply Chain and Logistics Product Portfolio Table 72. Brooks Life Sciences Recent Development Table 73. Hypertrust Patient Data Care Company Information Table 74. Hypertrust Patient Data Care Business Overview Table 75. Hypertrust Patient Data Care Cell and Gene Therapy Supply Chain and Logistics Revenue and Gross Margin (US$ Million) & (2021-2026) Table 76. Hypertrust Patient Data Care Cell and Gene Therapy Supply Chain and Logistics Product Portfolio Table 77. Hypertrust Patient Data Care Recent Development Table 78. Haemonetics Company Information Table 79. Haemonetics Business Overview Table 80. Haemonetics Cell and Gene Therapy Supply Chain and Logistics Revenue and Gross Margin (US$ Million) & (2021-2026) Table 81. Haemonetics Cell and Gene Therapy Supply Chain and Logistics Product Portfolio Table 82. Haemonetics Recent Development Table 83. MasterControl Company Information Table 84. MasterControl Business Overview Table 85. MasterControl Cell and Gene Therapy Supply Chain and Logistics Revenue and Gross Margin (US$ Million) & (2021-2026) Table 86. MasterControl Cell and Gene Therapy Supply Chain and Logistics Product Portfolio Table 87. MasterControl Recent Development Table 88. TraceLink Company Information Table 89. TraceLink Business Overview Table 90. TraceLink Cell and Gene Therapy Supply Chain and Logistics Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 91. TraceLink Cell and Gene Therapy Supply Chain and Logistics Product Portfolio Table 92. TraceLink Recent Development Table 93. TrakCel Company Information Table 94. TrakCel Business Overview Table 95. TrakCel Cell and Gene Therapy Supply Chain and Logistics Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 96. TrakCel Cell and Gene Therapy Supply Chain and Logistics Product Portfolio Table 97. TrakCel Recent Development Table 98. Stafa Cellular Therapy Company Information Table 99. Stafa Cellular Therapy Business Overview Table 100. Stafa Cellular Therapy Cell and Gene Therapy Supply Chain and Logistics Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 101. Stafa Cellular Therapy Cell and Gene Therapy Supply Chain and Logistics Product Portfolio Table 102. Stafa Cellular Therapy Recent Development Table 103. McKesson Company Information Table 104. McKesson Business Overview Table 105. McKesson Cell and Gene Therapy Supply Chain and Logistics Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 106. McKesson Cell and Gene Therapy Supply Chain and Logistics Product Portfolio Table 107. McKesson Recent Development Table 108. BioLife Solutions Company Information Table 109. BioLife Solutions Business Overview Table 110. BioLife Solutions Cell and Gene Therapy Supply Chain and Logistics Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 111. BioLife Solutions Cell and Gene Therapy Supply Chain and Logistics Product Portfolio Table 112. BioLife Solutions Recent Development Table 113. Patheon Company Information Table 114. Patheon Business Overview Table 115. Patheon Cell and Gene Therapy Supply Chain and Logistics Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 116. Patheon Cell and Gene Therapy Supply Chain and Logistics Product Portfolio Table 117. Patheon Recent Development Table 118. SF Express Company Information Table 119. SF Express Business Overview Table 120. SF Express Cell and Gene Therapy Supply Chain and Logistics Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 121. SF Express Cell and Gene Therapy Supply Chain and Logistics Product Portfolio Table 122. SF Express Recent Development Table 123. North America Cell and Gene Therapy Supply Chain and Logistics Revenue by Type (2021-2026) & (US$ Million) Table 124. North America Cell and Gene Therapy Supply Chain and Logistics Revenue by Type (2027-2032) & (US$ Million) Table 125. North America Cell and Gene Therapy Supply Chain and Logistics Revenue by Application (2021-2026) & (US$ Million) Table 126. North America Cell and Gene Therapy Supply Chain and Logistics Revenue by Application (2027-2032) & (US$ Million) Table 127. North America Cell and Gene Therapy Supply Chain and Logistics Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 128. North America Cell and Gene Therapy Supply Chain and Logistics Revenue by Country (2021-2026) & (US$ Million) Table 129. North America Cell and Gene Therapy Supply Chain and Logistics Revenue by Country (US$ Million) & (2027-2032) Table 130. Europe Cell and Gene Therapy Supply Chain and Logistics Revenue by Type (2021-2026) & (US$ Million) Table 131. Europe Cell and Gene Therapy Supply Chain and Logistics Revenue by Type (2027-2032) & (US$ Million) Table 132. Europe Cell and Gene Therapy Supply Chain and Logistics Revenue by Application (2021-2026) & (US$ Million) Table 133. Europe Cell and Gene Therapy Supply Chain and Logistics Revenue by Application (2027-2032) & (US$ Million) Table 134. Europe Cell and Gene Therapy Supply Chain and Logistics Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 135. Europe Cell and Gene Therapy Supply Chain and Logistics Revenue by Country (2021-2026) & (US$ Million) Table 136. Europe Cell and Gene Therapy Supply Chain and Logistics Revenue by Country (US$ Million) & (2027-2032) Table 137. China Cell and Gene Therapy Supply Chain and Logistics Revenue by Type (2021-2026) & (US$ Million) Table 138. China Cell and Gene Therapy Supply Chain and Logistics Revenue by Type (2027-2032) & (US$ Million) Table 139. China Cell and Gene Therapy Supply Chain and Logistics Revenue by Application (2021-2026) & (US$ Million) Table 140. China Cell and Gene Therapy Supply Chain and Logistics Revenue by Application (2027-2032) & (US$ Million) Table 141. Asia Cell and Gene Therapy Supply Chain and Logistics Revenue by Type (2021-2026) & (US$ Million) Table 142. Asia Cell and Gene Therapy Supply Chain and Logistics Revenue by Type (2027-2032) & (US$ Million) Table 143. Asia Cell and Gene Therapy Supply Chain and Logistics Revenue by Application (2021-2026) & (US$ Million) Table 144. Asia Cell and Gene Therapy Supply Chain and Logistics Revenue by Application (2027-2032) & (US$ Million) Table 145. Asia Cell and Gene Therapy Supply Chain and Logistics Revenue by Region (2021 VS 2025 VS 2032) & (US$ Million) Table 146. Asia Cell and Gene Therapy Supply Chain and Logistics Revenue by Region (US$ Million) & (2021-2026) Table 147. Asia Cell and Gene Therapy Supply Chain and Logistics Revenue by Region (US$ Million) & (2027-2032) Table 148. SAMEA Cell and Gene Therapy Supply Chain and Logistics Revenue by Type (2021-2026) & (US$ Million) Table 149. SAMEA Cell and Gene Therapy Supply Chain and Logistics Revenue by Type (2027-2032) & (US$ Million) Table 150. SAMEA Cell and Gene Therapy Supply Chain and Logistics Revenue by Application (2021-2026) & (US$ Million) Table 151. SAMEA Cell and Gene Therapy Supply Chain and Logistics Revenue by Application (2027-2032) & (US$ Million) Table 152. SAMEA Cell and Gene Therapy Supply Chain and Logistics Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 153. SAMEA Cell and Gene Therapy Supply Chain and Logistics Revenue by Country (2021-2026) & (US$ Million) Table 154. SAMEA Cell and Gene Therapy Supply Chain and Logistics Revenue by Country (US$ Million) & (2027-2032) Table 155. Research Programs/Design for This Report Table 156. Authors List of This Report Table 157. Secondary Sources Table 158. Primary Sources List of Figures Figure 1. Cell and Gene Therapy Supply Chain and Logistics Image Figure 2. Global Cell and Gene Therapy Supply Chain and Logistics Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Cell and Gene Therapy Supply Chain and Logistics Market Size Share 2021 VS 2025 VS 2032 Figure 4. Ordering and Scheduling Services Image Figure 5. Sample Collection Services Image Figure 6. Logistics Services Image Figure 7. Post Treatment Follow-Up Services Image Figure 8. Global Cell and Gene Therapy Supply Chain and Logistics Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 9. Global Cell and Gene Therapy Supply Chain and Logistics Market Size Share 2021 VS 2025 VS 2032 Figure 10. Biobank Image Figure 11. Cell Therapy Lab Image Figure 12. Hospital Image Figure 13. Research Institute Image Figure 14. Global Cell and Gene Therapy Supply Chain and Logistics Market Size (US$ Million) & (2021-2032) Figure 15. Global Cell and Gene Therapy Supply Chain and Logistics Market Size, (US$ Million), 2021 VS 2025 VS 2032 Figure 16. Global Cell and Gene Therapy Supply Chain and Logistics Market Share by Region: 2021 VS 2025 VS 2032 Figure 17. Global Cell and Gene Therapy Supply Chain and Logistics Players Revenue Share Top 10 and Top 5 in 2025 Figure 18. Players Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 19. Global Cell and Gene Therapy Supply Chain and Logistics Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 20. Global Cell and Gene Therapy Supply Chain and Logistics Revenue Market Share 2021 VS 2025 VS 2032 Figure 21. Global Cell and Gene Therapy Supply Chain and Logistics Revenue Market Share by Type (2021-2032) Figure 22. Global Cell and Gene Therapy Supply Chain and Logistics Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 23. Global Cell and Gene Therapy Supply Chain and Logistics Revenue Market Share by Application (2021 VS 2025 VS 2032) Figure 24. Global Cell and Gene Therapy Supply Chain and Logistics Revenue Market Share by Application (2021-2032) Figure 25. North America Cell and Gene Therapy Supply Chain and Logistics Revenue YoY Growth (2021-2032) & (US$ Million) Figure 26. North America Cell and Gene Therapy Supply Chain and Logistics Revenue Share by Type (2021-2032) Figure 27. North America Cell and Gene Therapy Supply Chain and Logistics Revenue Share by Application (2021-2032) Figure 28. North America Cell and Gene Therapy Supply Chain and Logistics Revenue Share by Country (2021-2032) Figure 29. United States Cell and Gene Therapy Supply Chain and Logistics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 30. Canada Cell and Gene Therapy Supply Chain and Logistics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 31. Mexico Cell and Gene Therapy Supply Chain and Logistics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 32. Europe Cell and Gene Therapy Supply Chain and Logistics Revenue YoY Growth (2021-2032) & (US$ Million) Figure 33. Europe Cell and Gene Therapy Supply Chain and Logistics Revenue Share by Type (2021-2032) Figure 34. Europe Cell and Gene Therapy Supply Chain and Logistics Revenue Share by Application (2021-2032) Figure 35. Europe Cell and Gene Therapy Supply Chain and Logistics Revenue Share by Country (2021-2032) Figure 36. Germany Cell and Gene Therapy Supply Chain and Logistics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 37. France Cell and Gene Therapy Supply Chain and Logistics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 38. U.K. Cell and Gene Therapy Supply Chain and Logistics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 39. Italy Cell and Gene Therapy Supply Chain and Logistics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 40. Spain Cell and Gene Therapy Supply Chain and Logistics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 41. Russia Cell and Gene Therapy Supply Chain and Logistics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 42. Netherlands Cell and Gene Therapy Supply Chain and Logistics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 43. Nordic Countries Cell and Gene Therapy Supply Chain and Logistics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 44. China Cell and Gene Therapy Supply Chain and Logistics Revenue YoY Growth (2021-2032) & (US$ Million) Figure 45. China Cell and Gene Therapy Supply Chain and Logistics Revenue Share by Type (2021-2032) Figure 46. China Cell and Gene Therapy Supply Chain and Logistics Revenue Share by Application (2021-2032) Figure 47. Asia Cell and Gene Therapy Supply Chain and Logistics Revenue YoY Growth (2021-2032) & (US$ Million) Figure 48. Asia Cell and Gene Therapy Supply Chain and Logistics Revenue Share by Type (2021-2032) Figure 49. Asia Cell and Gene Therapy Supply Chain and Logistics Revenue Share by Application (2021-2032) Figure 50. Asia Cell and Gene Therapy Supply Chain and Logistics Revenue Share by Region (2021-2032) Figure 51. Japan Cell and Gene Therapy Supply Chain and Logistics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 52. South Korea Cell and Gene Therapy Supply Chain and Logistics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 53. India Cell and Gene Therapy Supply Chain and Logistics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 54. Australia Cell and Gene Therapy Supply Chain and Logistics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 55. Taiwan Cell and Gene Therapy Supply Chain and Logistics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 56. Southeast Asia Cell and Gene Therapy Supply Chain and Logistics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 57. SAMEA Cell and Gene Therapy Supply Chain and Logistics Revenue YoY Growth (2021-2032) & (US$ Million) Figure 58. SAMEA Cell and Gene Therapy Supply Chain and Logistics Revenue Share by Type (2021-2032) Figure 59. SAMEA Cell and Gene Therapy Supply Chain and Logistics Revenue Share by Application (2021-2032) Figure 60. SAMEA Cell and Gene Therapy Supply Chain and Logistics Revenue Share by Country (2021-2032) Figure 61. Brazil Cell and Gene Therapy Supply Chain and Logistics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 62. Argentina Cell and Gene Therapy Supply Chain and Logistics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 63. Chile Cell and Gene Therapy Supply Chain and Logistics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 64. Colombia Cell and Gene Therapy Supply Chain and Logistics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 65. Peru Cell and Gene Therapy Supply Chain and Logistics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 66. Saudi Arabia Cell and Gene Therapy Supply Chain and Logistics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 67. Israel Cell and Gene Therapy Supply Chain and Logistics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 68. UAE Cell and Gene Therapy Supply Chain and Logistics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 69. Turkey Cell and Gene Therapy Supply Chain and Logistics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 70. Iran Cell and Gene Therapy Supply Chain and Logistics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 71. Egypt Cell and Gene Therapy Supply Chain and Logistics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 72. Years Considered Figure 73. Research Process Figure 74. Key Executives Interviewed

Scope & coverage.

Types
  • Ordering and Scheduling Services
  • Sample Collection Services
  • Logistics Services
  • Post Treatment Follow-Up Services
Applications
  • Biobank
  • Cell Therapy Lab
  • Hospital
  • Research Institute
Companies covered
  • Be The Match BioTherapies
  • Biocair
  • Marken
  • World Courier
  • MAK-SYSTEM
  • Cryoport
  • Brooks Life Sciences
  • Hypertrust Patient Data Care
  • Haemonetics
  • MasterControl
  • TraceLink
  • TrakCel
  • Stafa Cellular Therapy
  • McKesson
  • BioLife Solutions
  • Patheon
  • SF Express

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Cell and Gene Therapy Supply Chain and Logistics Market by Type
  3. 1.2.1 Global Cell and Gene Therapy Supply Chain and Logistics Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Ordering and Scheduling Services
  5. 1.2.3 Sample Collection Services
  6. 1.2.4 Logistics Services
  7. 1.2.5 Post Treatment Follow-Up Services
  8. 1.3 Cell and Gene Therapy Supply Chain and Logistics Market by Application
  9. 1.3.1 Global Cell and Gene Therapy Supply Chain and Logistics Market Size by Application, 2021 VS 2025 VS 2032
  10. 1.3.2 Biobank
  11. 1.3.3 Cell Therapy Lab
  12. 1.3.4 Hospital
  13. 1.3.5 Research Institute
  14. 1.4 Assumptions and Limitations
  15. 1.5 Study Goals and Objectives
2 Cell and Gene Therapy Supply Chain and Logistics Market Dynamics
  1. 2.1 Cell and Gene Therapy Supply Chain and Logistics Industry Trends
  2. 2.2 Cell and Gene Therapy Supply Chain and Logistics Industry Drivers
  3. 2.3 Cell and Gene Therapy Supply Chain and Logistics Industry Opportunities and Challenges
  4. 2.4 Cell and Gene Therapy Supply Chain and Logistics Industry Restraints
3 Global Growth Perspective
  1. 3.1 Global Cell and Gene Therapy Supply Chain and Logistics Market Perspective (2021-2032)
  2. 3.2 Global Cell and Gene Therapy Supply Chain and Logistics Growth Trends by Region
  3. 3.2.1 Global Cell and Gene Therapy Supply Chain and Logistics Market Size by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Cell and Gene Therapy Supply Chain and Logistics Market Size by Region (2021-2026)
  5. 3.2.3 Global Cell and Gene Therapy Supply Chain and Logistics Market Size by Region (2027-2032)
4 Competitive Landscape by Players
  1. 4.1 Global Cell and Gene Therapy Supply Chain and Logistics Revenue by Players
  2. 4.1.1 Global Cell and Gene Therapy Supply Chain and Logistics Revenue by Players (2021-2026)
  3. 4.1.2 Global Cell and Gene Therapy Supply Chain and Logistics Revenue Market Share by Players (2021-2026)
  4. 4.1.3 Global Cell and Gene Therapy Supply Chain and Logistics Players Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Cell and Gene Therapy Supply Chain and Logistics Key Players Ranking, 2024 VS 2025 VS 2026
  6. 4.3 Global Cell and Gene Therapy Supply Chain and Logistics Key Players Headquarters & Area Served
  7. 4.4 Global Cell and Gene Therapy Supply Chain and Logistics Players, Product Type & Application
  8. 4.5 Global Cell and Gene Therapy Supply Chain and Logistics Players Establishment Date
  9. 4.6 Market Competitive Analysis
  10. 4.6.1 Global Cell and Gene Therapy Supply Chain and Logistics Market CR5 and HHI
  11. 4.6.3 2025 Cell and Gene Therapy Supply Chain and Logistics Tier 1, Tier 2, and Tier 3
5 Cell and Gene Therapy Supply Chain and Logistics Market Size by Type
  1. 5.1 Global Cell and Gene Therapy Supply Chain and Logistics Revenue by Type (2021 VS 2025 VS 2032)
  2. 5.2 Global Cell and Gene Therapy Supply Chain and Logistics Revenue by Type (2021-2032)
  3. 5.3 Global Cell and Gene Therapy Supply Chain and Logistics Revenue Market Share by Type (2021-2032)
6 Cell and Gene Therapy Supply Chain and Logistics Market Size by Application
  1. 6.1 Global Cell and Gene Therapy Supply Chain and Logistics Revenue by Application (2021 VS 2025 VS 2032)
  2. 6.2 Global Cell and Gene Therapy Supply Chain and Logistics Revenue by Application (2021-2032)
  3. 6.3 Global Cell and Gene Therapy Supply Chain and Logistics Revenue Market Share by Application (2021-2032)
7 Company Profiles
  1. 7.1 Be The Match BioTherapies
  2. 7.1.1 Be The Match BioTherapies Company Information
  3. 7.1.2 Be The Match BioTherapies Business Overview
  4. 7.1.3 Be The Match BioTherapies Cell and Gene Therapy Supply Chain and Logistics Revenue and Gross Margin (2021-2026)
  5. 7.1.4 Be The Match BioTherapies Cell and Gene Therapy Supply Chain and Logistics Product Portfolio
  6. 7.1.5 Be The Match BioTherapies Recent Developments
  7. 7.2 Biocair
  8. 7.2.1 Biocair Company Information
  9. 7.2.2 Biocair Business Overview
  10. 7.2.3 Biocair Cell and Gene Therapy Supply Chain and Logistics Revenue and Gross Margin (2021-2026)
  11. 7.2.4 Biocair Cell and Gene Therapy Supply Chain and Logistics Product Portfolio
  12. 7.2.5 Biocair Recent Developments
  13. 7.3 Marken
  14. 7.3.1 Marken Company Information
  15. 7.3.2 Marken Business Overview
  16. 7.3.3 Marken Cell and Gene Therapy Supply Chain and Logistics Revenue and Gross Margin (2021-2026)
  17. 7.3.4 Marken Cell and Gene Therapy Supply Chain and Logistics Product Portfolio
  18. 7.3.5 Marken Recent Developments
  19. 7.4 World Courier
  20. 7.4.1 World Courier Company Information
  21. 7.4.2 World Courier Business Overview
  22. 7.4.3 World Courier Cell and Gene Therapy Supply Chain and Logistics Revenue and Gross Margin (2021-2026)
  23. 7.4.4 World Courier Cell and Gene Therapy Supply Chain and Logistics Product Portfolio
  24. 7.4.5 World Courier Recent Developments
  25. 7.5 MAK-SYSTEM
  26. 7.5.1 MAK-SYSTEM Company Information
  27. 7.5.2 MAK-SYSTEM Business Overview
  28. 7.5.3 MAK-SYSTEM Cell and Gene Therapy Supply Chain and Logistics Revenue and Gross Margin (2021-2026)
  29. 7.5.4 MAK-SYSTEM Cell and Gene Therapy Supply Chain and Logistics Product Portfolio
  30. 7.5.5 MAK-SYSTEM Recent Developments
  31. 7.6 Cryoport
  32. 7.6.1 Cryoport Company Information
  33. 7.6.2 Cryoport Business Overview
  34. 7.6.3 Cryoport Cell and Gene Therapy Supply Chain and Logistics Revenue and Gross Margin (2021-2026)
  35. 7.6.4 Cryoport Cell and Gene Therapy Supply Chain and Logistics Product Portfolio
  36. 7.6.5 Cryoport Recent Developments
  37. 7.7 Brooks Life Sciences
  38. 7.7.1 Brooks Life Sciences Company Information
  39. 7.7.2 Brooks Life Sciences Business Overview
  40. 7.7.3 Brooks Life Sciences Cell and Gene Therapy Supply Chain and Logistics Revenue and Gross Margin (2021-2026)
  41. 7.7.4 Brooks Life Sciences Cell and Gene Therapy Supply Chain and Logistics Product Portfolio
  42. 7.7.5 Brooks Life Sciences Recent Developments
  43. 7.8 Hypertrust Patient Data Care
  44. 7.8.1 Hypertrust Patient Data Care Company Information
  45. 7.8.2 Hypertrust Patient Data Care Business Overview
  46. 7.8.3 Hypertrust Patient Data Care Cell and Gene Therapy Supply Chain and Logistics Revenue and Gross Margin (2021-2026)
  47. 7.8.4 Hypertrust Patient Data Care Cell and Gene Therapy Supply Chain and Logistics Product Portfolio
  48. 7.8.5 Hypertrust Patient Data Care Recent Developments
  49. 7.9 Haemonetics
  50. 7.9.1 Haemonetics Company Information
  51. 7.9.2 Haemonetics Business Overview
  52. 7.9.3 Haemonetics Cell and Gene Therapy Supply Chain and Logistics Revenue and Gross Margin (2021-2026)
  53. 7.9.4 Haemonetics Cell and Gene Therapy Supply Chain and Logistics Product Portfolio
  54. 7.9.5 Haemonetics Recent Developments
  55. 7.10 MasterControl
  56. 7.10.1 MasterControl Company Information
  57. 7.10.2 MasterControl Business Overview
  58. 7.10.3 MasterControl Cell and Gene Therapy Supply Chain and Logistics Revenue and Gross Margin (2021-2026)
  59. 7.10.4 MasterControl Cell and Gene Therapy Supply Chain and Logistics Product Portfolio
  60. 7.10.5 MasterControl Recent Developments
  61. 7.11 TraceLink
  62. 7.11.1 TraceLink Company Information
  63. 7.11.2 TraceLink Business Overview
  64. 7.11.3 TraceLink Cell and Gene Therapy Supply Chain and Logistics Revenue and Gross Margin (2021-2026)
  65. 7.11.4 TraceLink Cell and Gene Therapy Supply Chain and Logistics Product Portfolio
  66. 7.11.5 TraceLink Recent Developments
  67. 7.12 TrakCel
  68. 7.12.1 TrakCel Company Information
  69. 7.12.2 TrakCel Business Overview
  70. 7.12.3 TrakCel Cell and Gene Therapy Supply Chain and Logistics Revenue and Gross Margin (2021-2026)
  71. 7.12.4 TrakCel Cell and Gene Therapy Supply Chain and Logistics Product Portfolio
  72. 7.12.5 TrakCel Recent Developments
  73. 7.13 Stafa Cellular Therapy
  74. 7.13.1 Stafa Cellular Therapy Company Information
  75. 7.13.2 Stafa Cellular Therapy Business Overview
  76. 7.13.3 Stafa Cellular Therapy Cell and Gene Therapy Supply Chain and Logistics Revenue and Gross Margin (2021-2026)
  77. 7.13.4 Stafa Cellular Therapy Cell and Gene Therapy Supply Chain and Logistics Product Portfolio
  78. 7.13.5 Stafa Cellular Therapy Recent Developments
  79. 7.14 McKesson
  80. 7.14.1 McKesson Company Information
  81. 7.14.2 McKesson Business Overview
  82. 7.14.3 McKesson Cell and Gene Therapy Supply Chain and Logistics Revenue and Gross Margin (2021-2026)
  83. 7.14.4 McKesson Cell and Gene Therapy Supply Chain and Logistics Product Portfolio
  84. 7.14.5 McKesson Recent Developments
  85. 7.15 BioLife Solutions
  86. 7.15.1 BioLife Solutions Company Information
  87. 7.15.2 BioLife Solutions Business Overview
  88. 7.15.3 BioLife Solutions Cell and Gene Therapy Supply Chain and Logistics Revenue and Gross Margin (2021-2026)
  89. 7.15.4 BioLife Solutions Cell and Gene Therapy Supply Chain and Logistics Product Portfolio
  90. 7.15.5 BioLife Solutions Recent Developments
  91. 7.16 Patheon
  92. 7.16.1 Patheon Company Information
  93. 7.16.2 Patheon Business Overview
  94. 7.16.3 Patheon Cell and Gene Therapy Supply Chain and Logistics Revenue and Gross Margin (2021-2026)
  95. 7.16.4 Patheon Cell and Gene Therapy Supply Chain and Logistics Product Portfolio
  96. 7.16.5 Patheon Recent Developments
  97. 7.17 SF Express
  98. 7.17.1 SF Express Company Information
  99. 7.17.2 SF Express Business Overview
  100. 7.17.3 SF Express Cell and Gene Therapy Supply Chain and Logistics Revenue and Gross Margin (2021-2026)
  101. 7.17.4 SF Express Cell and Gene Therapy Supply Chain and Logistics Product Portfolio
  102. 7.17.5 SF Express Recent Developments
8 North America
  1. 8.1 North America Cell and Gene Therapy Supply Chain and Logistics Revenue (2021-2032)
  2. 8.2 North America Cell and Gene Therapy Supply Chain and Logistics Revenue by Type (2021-2032)
  3. 8.2.1 North America Cell and Gene Therapy Supply Chain and Logistics Revenue by Type (2021-2026)
  4. 8.2.2 North America Cell and Gene Therapy Supply Chain and Logistics Revenue by Type (2027-2032)
  5. 8.3 North America Cell and Gene Therapy Supply Chain and Logistics Revenue Share by Type (2021-2032)
  6. 8.4 North America Cell and Gene Therapy Supply Chain and Logistics Revenue by Application (2021-2032)
  7. 8.4.1 North America Cell and Gene Therapy Supply Chain and Logistics Revenue by Application (2021-2026)
  8. 8.4.2 North America Cell and Gene Therapy Supply Chain and Logistics Revenue by Application (2027-2032)
  9. 8.5 North America Cell and Gene Therapy Supply Chain and Logistics Revenue Share by Application (2021-2032)
  10. 8.6 North America Cell and Gene Therapy Supply Chain and Logistics Revenue by Country
  11. 8.6.1 North America Cell and Gene Therapy Supply Chain and Logistics Revenue by Country (2021 VS 2025 VS 2032)
  12. 8.6.2 North America Cell and Gene Therapy Supply Chain and Logistics Revenue by Country (2021-2026)
  13. 8.6.3 North America Cell and Gene Therapy Supply Chain and Logistics Revenue by Country (2027-2032)
  14. 8.6.4 United States
  15. 8.6.5 Canada
  16. 8.6.6 Mexico
9 Europe
  1. 9.1 Europe Cell and Gene Therapy Supply Chain and Logistics Revenue (2021-2032)
  2. 9.2 Europe Cell and Gene Therapy Supply Chain and Logistics Revenue by Type (2021-2032)
  3. 9.2.1 Europe Cell and Gene Therapy Supply Chain and Logistics Revenue by Type (2021-2026)
  4. 9.2.2 Europe Cell and Gene Therapy Supply Chain and Logistics Revenue by Type (2027-2032)
  5. 9.3 Europe Cell and Gene Therapy Supply Chain and Logistics Revenue Share by Type (2021-2032)
  6. 9.4 Europe Cell and Gene Therapy Supply Chain and Logistics Revenue by Application (2021-2032)
  7. 9.4.1 Europe Cell and Gene Therapy Supply Chain and Logistics Revenue by Application (2021-2026)
  8. 9.4.2 Europe Cell and Gene Therapy Supply Chain and Logistics Revenue by Application (2027-2032)
  9. 9.5 Europe Cell and Gene Therapy Supply Chain and Logistics Revenue Share by Application (2021-2032)
  10. 9.6 Europe Cell and Gene Therapy Supply Chain and Logistics Revenue by Country
  11. 9.6.1 Europe Cell and Gene Therapy Supply Chain and Logistics Revenue by Country (2021 VS 2025 VS 2032)
  12. 9.6.2 Europe Cell and Gene Therapy Supply Chain and Logistics Revenue by Country (2021-2026)
  13. 9.6.3 Europe Cell and Gene Therapy Supply Chain and Logistics Revenue by Country (2027-2032)
  14. 9.6.4 Germany
  15. 9.6.5 France
  16. 9.6.6 U.K.
  17. 9.6.7 Italy
  18. 9.6.8 Russia
  19. 9.6.9 Spain
  20. 9.6.10 Netherlands
  21. 9.6.11 Switzerland
  22. 9.6.12 Sweden
  23. 9.6.13 Poland
10 China
  1. 10.1 China Cell and Gene Therapy Supply Chain and Logistics Revenue (2021-2032)
  2. 10.2 China Cell and Gene Therapy Supply Chain and Logistics Revenue by Type (2021-2032)
  3. 10.2.1 China Cell and Gene Therapy Supply Chain and Logistics Revenue by Type (2021-2026)
  4. 10.2.2 China Cell and Gene Therapy Supply Chain and Logistics Revenue by Type (2027-2032)
  5. 10.3 China Cell and Gene Therapy Supply Chain and Logistics Revenue Share by Type (2021-2032)
  6. 10.4 China Cell and Gene Therapy Supply Chain and Logistics Revenue by Application (2021-2032)
  7. 10.4.1 China Cell and Gene Therapy Supply Chain and Logistics Revenue by Application (2021-2026)
  8. 10.4.2 China Cell and Gene Therapy Supply Chain and Logistics Revenue by Application (2027-2032)
  9. 10.5 China Cell and Gene Therapy Supply Chain and Logistics Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Cell and Gene Therapy Supply Chain and Logistics Revenue (2021-2032)
  2. 11.2 Asia Cell and Gene Therapy Supply Chain and Logistics Revenue by Type (2021-2032)
  3. 11.2.1 Asia Cell and Gene Therapy Supply Chain and Logistics Revenue by Type (2021-2026)
  4. 11.2.2 Asia Cell and Gene Therapy Supply Chain and Logistics Revenue by Type (2027-2032)
  5. 11.3 Asia Cell and Gene Therapy Supply Chain and Logistics Revenue Share by Type (2021-2032)
  6. 11.4 Asia Cell and Gene Therapy Supply Chain and Logistics Revenue by Application (2021-2032)
  7. 11.4.1 Asia Cell and Gene Therapy Supply Chain and Logistics Revenue by Application (2021-2026)
  8. 11.4.2 Asia Cell and Gene Therapy Supply Chain and Logistics Revenue by Application (2027-2032)
  9. 11.5 Asia Cell and Gene Therapy Supply Chain and Logistics Revenue Share by Application (2021-2032)
  10. 11.6 Asia Cell and Gene Therapy Supply Chain and Logistics Revenue by Country
  11. 11.6.1 Asia Cell and Gene Therapy Supply Chain and Logistics Revenue by Country (2021 VS 2025 VS 2032)
  12. 11.6.2 Asia Cell and Gene Therapy Supply Chain and Logistics Revenue by Country (2021-2026)
  13. 11.6.3 Asia Cell and Gene Therapy Supply Chain and Logistics Revenue by Country (2027-2032)
  14. 11.6.4 Japan
  15. 11.6.5 South Korea
  16. 11.6.6 India
  17. 11.6.7 Australia
  18. 11.6.8 Taiwan
  19. 11.6.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Cell and Gene Therapy Supply Chain and Logistics Revenue (2021-2032)
  2. 12.2 SAMEA Cell and Gene Therapy Supply Chain and Logistics Revenue by Type (2021-2032)
  3. 12.2.1 SAMEA Cell and Gene Therapy Supply Chain and Logistics Revenue by Type (2021-2026)
  4. 12.2.2 SAMEA Cell and Gene Therapy Supply Chain and Logistics Revenue by Type (2027-2032)
  5. 12.3 SAMEA Cell and Gene Therapy Supply Chain and Logistics Revenue Share by Type (2021-2032)
  6. 12.4 SAMEA Cell and Gene Therapy Supply Chain and Logistics Revenue by Application (2021-2032)
  7. 12.4.1 SAMEA Cell and Gene Therapy Supply Chain and Logistics Revenue by Application (2021-2026)
  8. 12.4.2 SAMEA Cell and Gene Therapy Supply Chain and Logistics Revenue by Application (2027-2032)
  9. 12.5 SAMEA Cell and Gene Therapy Supply Chain and Logistics Revenue Share by Application (2021-2032)
  10. 12.6 SAMEA Cell and Gene Therapy Supply Chain and Logistics Revenue by Country
  11. 12.6.1 SAMEA Cell and Gene Therapy Supply Chain and Logistics Revenue by Country (2021 VS 2025 VS 2032)
  12. 12.6.2 SAMEA Cell and Gene Therapy Supply Chain and Logistics Revenue by Country (2021-2026)
  13. 12.6.3 SAMEA Cell and Gene Therapy Supply Chain and Logistics Revenue by Country (2027-2032)
  14. 12.6.4 Brazil
  15. 12.6.5 Argentina
  16. 12.6.6 Chile
  17. 12.6.7 Colombia
  18. 12.6.8 Peru
  19. 12.6.9 Saudi Arabia
  20. 12.6.10 Israel
  21. 12.6.11 UAE
  22. 12.6.12 Turkey
  23. 12.6.13 Iran
  24. 12.6.14 Egypt
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst